News | January 22, 2025
Catalent to further expand Galapagos’ decentralized CAR-T manufacturing network in US
New Jersey-based manufacturing site to support innovative decentralized approach for improved patient experience
New Jersey-based manufacturing site to support innovative decentralized approach for improved patient experience
The project will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines
SIM0500 is a humanized trispecific antibody that targets GPRC5D, BCMA, and CD3
Regulatory filings underway for a third indication for darolutamide in prostate cancer, for finerenone in a common form of heart failure, and acoramidis in transthyretin amyloid
If approved, sasanlimab would be the first PD-1 inhibitor, in combination with BCG, to significantly prolong event-free survival in this patient population
The primary objective of the study is to assess the safety and tolerability of SUVN-I6107 by monitoring adverse events (AEs), clinical laboratory, vital signs and electrocardiographs
Innovent has granted Roche exclusive global rights to develop, manufacture and commercialize IBI3009
Merck will record a pre-tax charge relating to the upfront payment of $588 million
An investigational long-acting monoclonal antibody designed to protect infants from RSV disease during their first RSV season
Merck has also decided to end the favezelimab clinical development program
Subscribe To Our Newsletter & Stay Updated
